Workflow
Newsfile
icon
Search documents
CPTN DEADLINE: ROSEN, A HIGHLY RANKED LAW FIRM, Encourages Cepton, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CPTN
Newsfile· 2025-11-17 00:00
CPTN DEADLINE: ROSEN, A HIGHLY RANKED LAW FIRM, Encourages Cepton, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CPTNNovember 16, 2025 7:00 PM EST | Source: The Rosen Law Firm PANew York, New York--(Newsfile Corp. - November 16, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers or sellers of common stock of Cepton, Inc. (NASDAQ: CPTN) between July 29, 2024 and January 6, 2025, both dates inclusive (the "Class Period"), ...
ROSEN, A GLOBAL INVESTOR RIGHTS LAW FIRM, Encourages Avantor, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AVTR
Newsfile· 2025-11-16 23:15
Core Viewpoint - Rosen Law Firm is encouraging investors of Avantor, Inc. to secure legal counsel before the December 29, 2025 deadline for a securities class action lawsuit related to stock purchases made between March 5, 2024, and October 28, 2025 [1] Group 1: Class Action Details - Investors who purchased Avantor common stock during the specified class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - To participate in the class action, investors must act before the lead plaintiff deadline of December 29, 2025, and can do so by contacting Rosen Law Firm [3][6] - The lawsuit alleges that Avantor's competitive positioning was misrepresented, and that the company faced negative impacts from increased competition, leading to materially false and misleading statements about its business and prospects [5] Group 2: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked No. 1 for the number of settlements in 2017 [4] - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4] - Founding partner Laurence Rosen was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020, highlighting the firm's expertise and success in this area [4]
ROSEN, A LEADING GLOBAL INVESTOR RIGHTS LAW FIRM, Encourages CarMax, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - KMX
Newsfile· 2025-11-16 22:18
Core Viewpoint - Rosen Law Firm is encouraging investors of CarMax, Inc. to secure legal counsel before the January 2, 2026 deadline for a securities class action lawsuit related to the company's misleading statements during the class period from June 20, 2025, to November 5, 2025 [1][5]. Group 1: Class Action Details - Investors who purchased CarMax securities during the specified class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by January 2, 2026 [3][6]. - The lawsuit alleges that CarMax's defendants made materially false statements regarding the company's growth prospects, which were based on temporary benefits rather than sustainable growth [5]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company and being ranked No. 1 for securities class action settlements in 2017 [4]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4]. - Many attorneys at Rosen Law Firm have received recognition from Lawdragon and Super Lawyers, highlighting the firm's expertise in this area [4].
LRN INVESTOR ALERT: Stride, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Newsfile· 2025-11-16 21:05
Core Viewpoint - Stride, Inc. is facing a class action lawsuit alleging violations of the Securities Exchange Act of 1934, with claims of misleading statements and non-compliance with legal requirements during the class period from October 22, 2024, to October 28, 2025 [1][3]. Allegations - The lawsuit claims that Stride inflated enrollment numbers by retaining "ghost students" and cut staffing costs by overloading teachers beyond statutory limits [3]. - It is alleged that Stride ignored compliance requirements, including background checks and special education services, and suppressed whistleblowers who reported financial directives to delay hiring and deny services [3]. - A complaint from Gallup-McKinley County Schools against Stride included allegations of fraud and deceptive practices, leading to a nearly 12% drop in Stride's stock price [4]. - Following a report of "poor customer experience," Stride estimated a loss of 10,000-15,000 enrollments, resulting in a more than 54% decline in stock price [5]. Legal Process - Investors who purchased Stride securities during the class period can seek appointment as lead plaintiff in the lawsuit, representing the interests of the class [6]. Firm Background - Robbins Geller Rudman & Dowd LLP is a leading law firm in securities fraud litigation, having recovered over $2.5 billion for investors in 2024 alone [7].
FLY INVESTOR ALERT: Firefly Aerospace Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Newsfile· 2025-11-16 21:00
Core Viewpoint - Firefly Aerospace Inc. is facing a class action lawsuit due to alleged violations of securities laws, with claims that the company misrepresented its business prospects and financial performance during its IPO and subsequent reporting period [1][3][4]. Company Overview - Firefly Aerospace operates in the space and defense technology sector, providing mission solutions for national security, government, and commercial customers [2]. IPO Details - The company conducted its initial public offering (IPO) on August 7, 2025, issuing approximately 19.3 million shares at an offering price of $45.00 per share [2]. Allegations of Misrepresentation - The lawsuit alleges that Firefly Aerospace overstated demand and growth prospects for its Spacecraft Solutions offerings and the operational readiness of its Alpha rocket program [3]. - It is claimed that these misrepresentations would likely have a material negative impact on the company once revealed [3]. Financial Performance - In its first earnings report as a public company on September 22, 2025, Firefly Aerospace reported a loss of $80.3 million for Q2 2025, compared to a loss of $58.7 million in Q2 2024 [4]. - The company reported revenue of $15.55 million, which was below analyst estimates of $17.25 million and represented a 26.2% decrease from the same quarter in 2024 [4]. - Revenue from the Spacecraft Solutions segment was particularly concerning, showing a 49% year-over-year decrease to only $9.2 million [4]. Stock Price Impact - Following the earnings report, Firefly Aerospace's stock price fell by more than 15% [4]. - On September 29, 2025, the company disclosed an issue with its Alpha Flight 7 rocket, leading to a further decline in stock price by more than 20% [5].
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Stride, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - LRN
Newsfile· 2025-11-16 19:11
Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of purchasers of securities of Stride, Inc. for the period between October 22, 2024, and October 28, 2025, due to misleading statements and omissions regarding the company's products and services [1][5]. Group 1: Lawsuit Details - The class action lawsuit claims that Stride, Inc. made misleading statements about its products and services aimed at public and private schools, which included inflated enrollment numbers and non-compliance with statutory requirements [5]. - Investors are entitled to compensation without any out-of-pocket fees through a contingency fee arrangement if they purchased Stride, Inc. securities during the class period [2]. Group 2: Next Steps for Investors - Interested investors can join the class action by visiting the provided link or contacting the law firm directly for more information [3][6]. - A lead plaintiff must file a motion with the court by January 12, 2026, to represent other class members in the litigation [1][3]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company [4]. - The firm has been consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions of dollars for investors [4].
Buy Firewood Direct Celebrates a Decade of Supplying Kiln Dried Logs Across the UK
Newsfile· 2025-11-16 18:11
Company Overview - Buy Firewood Direct Limited was established in February 2014 and is celebrating its tenth anniversary of supplying kiln-dried hardwood fuel across the UK [2][9] - The company specializes in kiln-dried logs, including mixed hardwoods, birch, and oak, available in various packaging formats to meet customer needs [4][9] Industry Trends & Market Context - The UK firewood market has seen a significant shift, with households increasingly opting for kiln-dried logs due to their lower moisture content, cleaner burn, and compatibility with modern wood-burning appliances [5] - The UK consumes approximately 2 million tonnes of firewood annually, highlighting the critical role of wood fuel in domestic heating and renewable energy [5] Demand and Supply Dynamics - Colder seasons drive increased demand for efficient heating fuel, positioning companies like Buy Firewood Direct as key players in the supply chain of quality logs across the nation [6] Future Outlook - As it enters its second decade, Buy Firewood Direct aims to focus on innovation in fuel supply, expand its product offerings, and maintain its commitment to quality, value, and service [8] - The company prioritizes customer convenience through online ordering and fast delivery [8]
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Primo Brands Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - PRMB, PRMW
Newsfile· 2025-11-16 16:40
Core Viewpoint - A class action lawsuit has been filed on behalf of investors in Primo Water Corporation and Primo Brands Corporation, alleging misrepresentation and failure to disclose key facts regarding the merger between the two companies, which led to investor losses during the specified Class Periods [2][6]. Group 1: Class Action Details - The class action lawsuit covers purchasers of common stock of Primo Water Corporation from June 17, 2024, to November 8, 2024, and purchasers of common stock of Primo Brands Corporation from November 11, 2024, to November 6, 2025 [2]. - Investors who purchased securities during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3]. Group 2: Legal Representation - Investors are encouraged to select qualified legal counsel with a successful track record in securities class actions, as the Rosen Law Firm has achieved significant settlements and recognition in this field [5]. - The Rosen Law Firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [5]. Group 3: Allegations Against Defendants - The lawsuit claims that the defendants made materially false and misleading statements about the merger's progress, leading investors to believe in accelerated growth and strong financial results [6]. - The merger between Primo Water and BlueTriton Brands was misrepresented as proceeding "flawlessly," which contributed to investor damages when the true details emerged [6].
Important Notice to Long-Term Shareholders of Fluor Corporation (FLR): Grabar Law Office Investigates Claims on Your Behalf
Newsfile· 2025-11-16 16:19
Core Viewpoint - Grabar Law Office is investigating claims on behalf of shareholders of Fluor Corporation regarding potential breaches of fiduciary duties by certain officers and directors [1] Group 1: Investigation Details - The investigation is focused on whether Fluor Corporation's officers made materially false and misleading statements and failed to disclose adverse facts about the company's business and operations [3] - Allegations include that costs for specific projects were increasing due to subcontractor errors, price hikes, and scheduling delays, which negatively impacted the company's financial results [3] - The investigation suggests that Fluor's financial guidance for FY 2025 was unreliable, and the effectiveness of its risk mitigation strategies was overstated [3] Group 2: Shareholder Actions - Shareholders who purchased Fluor Corporation shares before February 18, 2025, and still hold them can seek corporate reforms and the return of funds at no cost [2][4] - Interested shareholders are encouraged to contact Grabar Law Office for more information on the investigation and potential actions [2][4]
CYTK DEADLINE: ROSEN, A HIGHLY RANKED LAW FIRM, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important November 17 Deadline in Securities Class Action - CYTK
Newsfile· 2025-11-16 15:35
Core Viewpoint - Rosen Law Firm is encouraging investors of Cytokinetics, Inc. to secure legal counsel before the November 17, 2025 deadline related to a securities class action lawsuit [1][3]. Group 1: Class Action Details - Investors who purchased Cytokinetics common stock between December 27, 2023, and May 6, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by November 17, 2025 [3]. Group 2: Legal Representation - Investors are advised to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [4]. - The Rosen Law Firm has a history of significant settlements, including the largest securities class action settlement against a Chinese company, and has recovered hundreds of millions for investors [4]. Group 3: Case Background - The lawsuit alleges that Cytokinetics made false or misleading statements regarding the timeline for the New Drug Application (NDA) submission and approval process for aficamten, specifically regarding expected FDA approval in the second half of 2025 [5]. - The company failed to disclose material risks related to the submission of a Risk Evaluation and Mitigation Strategy (REMS), which could delay the regulatory process, leading to investor damages when the true details became public [5].